Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Overcoming ischemia in the diabetic foot: Minimally invasive treatment options.

Authors:
Stavros Spiliopoulos Georgios Festas Ioannis Paraskevopoulos Martin Mariappan Elias Brountzos

World J Diabetes 2021 Dec;12(12):2011-2026

Second Department of Radiology, School of Medicine; National and Kapodistrian University of Athens, Athens 12461, Greece.

As the global burden of diabetes is rapidly increasing, the incidence of diabetic foot ulcers is continuously increasing as the mean age of the world population increases and the obesity epidemic advances. A significant percentage of diabetic foot ulcers are caused by mixed micro and macro-vascular dysfunction leading to impaired perfusion of foot tissue. Left untreated, chronic limb-threatening ischemia has a poor prognosis and is correlated with limb loss and increased mortality; prompt treatment is required. In this review, the diagnostic challenges in diabetic foot disease are discussed and available data on minimally invasive treatment options such as endovascular revascularization, stem cells, and gene therapy are examined.

Download full-text PDF

Source
http://dx.doi.org/10.4239/wjd.v12.i12.2011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696640PMC
December 2021

Publication Analysis

Top Keywords

diabetic foot
16
invasive treatment
8
treatment options
8
foot ulcers
8
minimally invasive
8
foot
5
impaired perfusion
4
overcoming ischemia
4
leading impaired
4
dysfunction leading
4
foot disease
4
macro-vascular dysfunction
4
micro macro-vascular
4
therapy examined
4
disease discussed
4
challenges diabetic
4
mixed micro
4
caused mixed
4
discussed data
4
ulcers caused
4

Keyword Occurance

Similar Publications

Moderate to Severe Soft Tissue Diabetic Foot Infections: A Randomized, Controlled, Pilot Trial of Post-Debridement Antibiotic Treatment for 10 versus 20 days.

Authors:
Truong-Thanh Pham Karim Gariani Jean-Christophe Richard Benjamin Kressmann Francois Jornayvaz Jacques Philippe Benjamin A Lipsky Ilker Uckay

Ann Surg 2021 Sep 15. Epub 2021 Sep 15.

Service of Infectious Diseases.

Background: The optimal duration of antibiotic therapy for soft-tissue infections of the diabetic foot (ST-DFI) remains unknown.

Objective: We determine if antibiotic therapy after debridement for a short (10 days), compared with a long (20 days), duration for ST-DFI results in similar rates of clinical remission and adverse events (AE).

Summary Background Data: The optimal duration of systemic antibiotic therapy, after successful debridement, for soft tissue infections of diabetic patients is unknown. Read More

View Article and Full-Text PDF
September 2021
Similar Publications

Phloretin ameliorates diabetic nephropathy by inhibiting nephrin and podocin reduction through a non-hypoglycemic effect.

Authors:
Jia Liu Mingcheng Sun Yong Xia Xiaopei Cui Jingjing Jiang

Food Funct 2022 May 27. Epub 2022 May 27.

Department of Pharmacology, School of Basic Medical Sciences, Shandong University, Jinan, Shandong, PR China.

Phloretin is a dihydrochalcone flavonoid from natural plants, which has protective activities against oxidative stress and inflammation. To date, its effect on diabetic nephropathy (DN) has not been investigated. In this study, we examined the potential role of phloretin in diabetes-induced renal damage and associated mechanisms in a type 2 diabetes mellitus (T2DM) model induced by streptozotocin (STZ) and high-fat diet (HFD) in Apolipoprotein E knockout () mice. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

Nrf2 driven macrophage responses in diverse pathophysiological contexts: Disparate pieces from a shared molecular puzzle.

Authors:
Goutham V Ganesh Kumar Ganesan Baojun Xu Kunka Mohanram Ramkumar

Biofactors 2022 May 26. Epub 2022 May 26.

Department of Biotechnology, School of Bioengineering, SRM Institute of Science & Technology, Kattankulathur, Tamil Nadu, India.

The wide anatomical distribution of macrophages and their vast array of functions match various polarization states and their involvement in homeostasis and disease. The confluence of different cellular signaling networks, including direct involvement in inflammation, at the doorstep of the transcription factor Nuclear Factor- erythroid (NF-E2) p45-related factor 2 (Nrf2) activation raises the importance of deciphering the molecular circuitry at the background of multiple-discrete and antagonistic yet flexible and contextual pathways. While we primarily focus on wound healing and repair mechanisms that are affected in diabetic foot ulcers (DFUs), we strive to explore the striking similarities and differences in molecular events including inflammation, angiogenesis, and fibrosis during tissue injury and wound persistence that accumulates pro-inflammatory senescent macrophages, as a means to identify possible targets or cellular mediators to lessen DFU disease burden. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

Diabetes mellitus and diabetic foot ulcer: Etiology, biochemical and molecular based treatment strategies via gene and nanotherapy.

Authors:
Arokia Vijaya Anand Mariadoss Allur Subramaniyan Sivakumar Chang-Hun Lee Sung Jae Kim

Biomed Pharmacother 2022 May 24;151:113134. Epub 2022 May 24.

Department of Orthopaedic Surgery, Dongtan Sacred Heart Hospital, Hallym University, College of Medicine, Hwaseong, Republic of Korea. Electronic address:

Diabetes mellitus (DM) is a collection of metabolic and pathophysiological disorders manifested with high glucose levels in the blood due to the inability of β-pancreatic cells to secrete an adequate amount of insulin or insensitivity of insulin towards receptor to oxidize blood glucose. Nevertheless, the preceding definition is only applicable to people who do not have inherited or metabolic disorders. Suppose a person who has been diagnosed with Type 1 or Type 2DM sustains an injury and the treatment of the damage is complicated and prolonged. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

Crosstalk between Sirtuins and Nrf2: SIRT1 activators as emerging treatment for diabetic neuropathy.

Authors:
Shivangi Patel Hasnat Khan Anuradha Majumdar

Metab Brain Dis 2022 May 26. Epub 2022 May 26.

Department of Pharmacology, Bombay College of Pharmacy, Kalina, Santacruz (E), Mumbai, 400098, India.

About 50% of the diabetic patients worldwide suffer from Diabetic peripheral neuropathy (DPN) which is characterized by chronic pain and loss of sensation, frequent foot ulcerations, and risk for amputation. Numerous factors like hyperglycemia, oxidative stress (OS), impaired glucose signaling, inflammatory responses, neuronal cell death are known to be the various mechanisms underlying DACD and DPN. Development of tolerance, insufficient and inadequate relief and potential toxicity of classical antinociceptives still remains a challenge in the clinical setting. Read More

View Article and Full-Text PDF
May 2022
Similar Publications
}
© 2022 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap